This file is part of IDEAS , which uses RePEc data
[ Papers |
Articles |
Software |
Books |
Chapters |
Authors |
Institutions |
JEL Classification |
NEP reports |
Search |
New papers by email |
Author registration |
Rankings |
Volunteers |
FAQ |
Blog |
Help! ]
Research classified by
Journal of
Economic Literature (JEL) codes Top JEL C: Mathematical and Quantitative Methods C0 : GeneralC1 : Econometric and Statistical Methods: GeneralC2 : Single Equation Models; Single VariablesC3 : Multiple or Simultaneous Equation Models; Multiple VariablesC4 : Econometric and Statistical Methods: Special TopicsC5 : Econometric ModelingC6 : Mathematical Methods and ProgrammingC7 : Game Theory and Bargaining TheoryC8 : Data Collection and Data Estimation Methodology; Computer ProgramsC9 : Design of Experiments2008 Aid and Trade - A Donor´s Perspective by Felicitas Nowak-Lehmann D. & Inmaculada Martínez-Zarzoso & Stephan Klasen & Dierk Herzer [Downloadable!] 2008 Association Between Measures of Fatigue and Health-Related Quality of Life in Rheumatoid Arthritis and Osteoarthritis by Marita Cross & Helen Lapsley & Annica Barcenilla & Peter Brooks & Lyn March [Downloadable!] 2008 The Relationship Between Physician Friendliness and Caring, and Patient Satisfaction: Findings from an Internet-Based Survey by Adam A. Uhas & Fabian T. Camacho & Steven R. Feldman & Rajesh Balkrishnan [Downloadable!] 2008 Does Behavioral Bootstrapping Boost Weight Control Confidence?: A Pilot Study by James E. Rohrer & Kristin S. Vickers-Douglas & Robert J. Stroebel [Downloadable!] 2008 Making Patient-Centered Care More Visible: Planetree's Vision by Carrie Brady [Downloadable!] 2008 Honoring the Life of a Pioneer in Patient-Centered Care: Harvey Picker, PhD (1915-2008) by Susan B. Frampton & Sara Guastello [Downloadable!] 2008 Translation and Validation of the Chinese Diabetic Foot Ulcer Scale - Short Form by Lan Fong Hui & Daniel Yee-Tak Fong & Michael Yam & Wing Yuk Ip [Downloadable!] 2008 The Use of Multi-Criteria Decision Analysis Weight Elicitation Techniques in Patients with Mild Cognitive Impairment: A Pilot Study by Janine A. van Til & James G. Dolan & Anne M. Stiggelbout & Karin C.G.M. Groothuis & Maarten J. IJzerman [Downloadable!] 2008 Psychometric Performance of the National Eye Institute 25-Item Visual Function Questionnaire: In Turkish Diabetic Retinopathy Patients by Akinci Fevzi & Yildirim Aysegul [Downloadable!] 2008 A Randomized Study of Electronic Diary versus Paper and Pencil Collection of Patient-Reported Outcomes in Patients with Non-Small Cell Lung Cancer by Alistair E. Ring & Kerry A. Cheong & Claire L. Watkins & David Meddis & David Cella & Peter G. Harper [Downloadable!] 2008 Lillie Shockney: Breast Cancer Survivor, Advocate, and Researcher by John F.P. Bridges [Downloadable!] 2008 When Time is Not on Your Side: Patient Experiences with Waiting for Home Care and Admission to a Nursing or Residential Home by N. Job A. van Exel & Marion de Ruiter & Werner B.F. Brouwer [Downloadable!] 2008 Honoring Pioneers in Patient-Centered Outcomes Research by John F.P. Bridges & Christopher I. Carswell [Downloadable!] 2008 Obesity Modifies the Association of Race/Ethnicity with Medication Adherence in the CARDIA Study by Maribel Salas & Catarina I. Kiefe & Pamela J. Schreiner & Yongin Kim & Lucia Juarez & Sharina D. Person & O. Dale Williams [Downloadable!] 2008 Age and Choice in Health Insurance: Evidence from a Discrete Choice Experiment by Karolin Becker & Peter Zweifel [Downloadable!] 2008 If You Want Patients with Knee Osteoarthritis to Exercise, Tell Them about NSAIDs by Liana Fraenkel & Terri Fried [Downloadable!] 2008 Concordance of Couples by Scott B. Cantor & Robert J. Volk & Murray D. Krahn & Alvah R. Cass & Jawaria Gilani & Susan C. Weller & Stephen J. Spann [Downloadable!] 2008 The Role of The Patient in Promoting Patient-Centered Outcomes Research by Michael J. Klag & Ellen J. MacKenzie & Christopher I. Carswell & John F.P. Bridges [Downloadable!] 2008 Cost Effectiveness of the German Screen-and-Treat Strategy for Postmenopausal Osteoporosis by Dirk Mueller & Eva Weyler & Afschin Gandjour [Downloadable!] 2008 Cost-Utility Analysis of Varenicline versus Existing Smoking Cessation Strategies using the BENESCO Simulation Model: Application to a Population of US Adult Smokers by Paul Howard & Christopher Knight & Annabel Boler & Christine Baker [Downloadable!] 2008 Guidelines for Conducting Pharmaceutical Budget Impact Analyses for Submission to Public Drug Plans in Canada by Deborah A. Marshall & Patrick R. Douglas & Michael F. Drummond & George W. Torrance & Stuart MacLeod & Orlando Manti & Lokanadha Cheruvu & Ron Corvari [Downloadable!] 2008 Cost of Epilepsy: A Systematic Review by Adam Strzelczyk & Jens Peter Reese & Richard Dodel & Hajo M. Hamer [Downloadable!] 2008 Economic Burden of Heart Failure in the Elderly by Lawrence Liao & Larry A. Allen & David J. Whellan [Downloadable!] 2008 Updated Estimates of Survival and Cost Effectiveness for Imatinib versus Interferon-alpha Plus Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukaemia by Shelby D. Reed & Kevin J. Anstrom & Yanhong Li & Kevin A. Schulman [Downloadable!] 2008 A Multicentre, Prospective Study to Evaluate Costs of Septic Patients in Brazilian Intensive Care Units by Ana M.C. Sogayar & Flavia R. Machado & Alvaro Rea-Neto & Amselmo Dornas & Cintia M.C. Grion & Suzana M.A. Lobo & Bernardo R. Tura & Carla L.O. Silva & Ruy G.R. Cal & Idal Beer & Vilto Michels & Jorge Safi & Marcia Kayath & Eliezer Silva [Downloadable!] 2008 Methodological Issues in Evaluating Cost Effectiveness of Adjuvant Aromatase Inhibitors in Early Breast Cancer: A Need for Improved Modelling to Aid Decision Making by Lieven Annemans [Downloadable!] 2008 Economic Evaluations in Rheumatoid Arthritis: A Critical Review of Measures Used to Define Health States by Nick Bansback & Roberta Ara & Jonathan Karnon & Aslam Anis [Downloadable!] 2008 Economic Evaluation of Interventions to Treat Opiate Dependence: A Review of the Evidence by Christopher M. Doran [Downloadable!] 2008 Perspectives on Patient-Reported Outcomes: Content Validity and Qualitative Research in a Changing Clinical Trial Environment by Nancy Kline Leidy & Margaret Vernon [Downloadable!] 2008 Cost-Effectiveness Analysis: Developing Nations Left Behind by Mendel E. Singer [Downloadable!] 2008 Cost-Utility Analysis of Treatment with Olanzapine Compared with Other Antipsychotic Treatments in Patients with Schizophrenia in the Pan-European SOHO Study by Martin Knapp & Frank Windmeijer & Jacqueline Brown & Stathis Kontodimas & Spyridon Tzivelekis & Josep Maria Haro & Mark Ratcliffe & Jihyung Hong & Diego Novick [Downloadable!] 2008 An Economic Evaluation of Atorvastatin for Primary Prevention of Cardiovascular Events in Type 2 Diabetes by Scott D. Ramsey & Lauren D. Clarke & Craig S. Roberts & Sean D. Sullivan & Scott J. Johnson & Larry Z. Liu [Downloadable!] 2008 Cost Effectiveness of Ibandronate for the Prevention of Fractures in Inflammatory Bowel Disease-Related Osteoporosis: Cost-Utility Analysis Using a Markov Model by Simon Kreck & Jochen Klaus & Reiner Leidl & Christian von Tirpitz & Alexander Konnopka & Herbert Matschinger & Hans-Helmut Konig [Downloadable!] 2008 The Use of QALY Weights for QALY Calculations: A Review of Industry Submissions Requesting Listing on the Australian Pharmaceutical Benefits Scheme 2002-4 by Paul A. Scuffham & Jennifer A. Whitty & Andrew Mitchell & Rosalie Viney [Downloadable!] 2008 Making a Case for Employing a Societal Perspective in the Evaluation of Medicaid Prescription Drug Interventions by Sanjoy Roy & S. Suresh Madhavan [Downloadable!] 2008 An Overview of Methods and Applications to Value Informal Care in Economic Evaluations of Healthcare by Marc A. Koopmanschap & N. Job A. van Exel & Bernard van den Berg & Werner B.F. Brouwer [Downloadable!] 2008 Zoledronic Acid: A Pharmacoeconomic Review of its Use in the Management of Bone Metastases by Kate McKeage & Greg L. Plosker [Downloadable!] 2008 Community and Patient Values for Preventing Herpes Zoster by Tracy A. Lieu & Ismael Ortega-Sanchez & G. Thomas Ray & Donna Rusinak & W. Katherine Yih & Peter W. Choo & Irene Shui & Ken Kleinman & Rafael Harpaz & Lisa A. Prosser [Downloadable!] 2008 Preferences of Patients with Diabetes Mellitus for Inhaled versus Injectable Insulin Regimens by Jeremy Chancellor & Samuel Aballea & Alison Lawrence & Rob Sheldon & Sandrine Cure & Juliette Plun-Favreau & Nick Marchant [Downloadable!] 2008 Cost-Effectiveness Analyses of Vaccination Programmes: A Focused Review of Modelling Approaches by Sun-Young Kim & Sue J. Goldie [Downloadable!] 2008 Projecting Vaccine Efficacy: Accounting for Geographic Strain Variations by Johnie Rose & Mendel E. Singer [Downloadable!] 2008 Transparency of Economic Evaluations of Health Technologies by Joan Rovira [Downloadable!] 2008 Meandering Down the Road to Transparency by Christopher I. Carswell & Joseph A. Paladino [Downloadable!] 2008 Management of Anaemia: A Critical and Systematic Review of the Cost Effectiveness of Erythropoiesis-Stimulating Agents by Mei Sheng Duh & Jennifer R. Weiner & Leigh Ann White & Patrick Lefebvre & Paul E. Greenberg [Downloadable!] 2008 Having Your Cake and Eating It: Office of Fair Trading Proposal for Funding New Drugs to Benefit Patients and Innovative Companies by Brian Godman & Alan Haycox & Ulrich Schwabe & Roberta Joppi & Silvio Garattini [Downloadable!] 2008 Non-Traditional Settings for Influenza Vaccination of Adults: Costs and Cost Effectiveness by Lisa A. Prosser & Megan A. OBrien & Noelle-Angelique M. Molinari & Katherine H. Hohman & Kristin L. Nichol & Mark L. Messonnier & Tracy A. Lieu [Downloadable!] 2008 The Burden of Schizophrenia on Caregivers: A Review by A. George Awad & Lakshmi N.P. Voruganti [Downloadable!] 2008 Modelling Methods for Pharmacoeconomics and Health Technology Assessment: An Overview and Guide by James E. Stahl [Downloadable!] 2008 Economic Burden of Psoriatic Arthritis by Christoph Ackermann & Arthur Kavanaugh [Downloadable!] 2008 Cost Effectiveness of Itraconazole in the Prophylaxis of Invasive Fungal Infections by Robin de Vries & Simon Daenen & Keith Tolley & Axel Glasmacher & Archie Prentice & Sarah Howells & Hariette Christopherson & Lolkje T.W. de Jong-van den Berg & Maarten J. Postma [Downloadable!] 2008 Economic Burden of Bilateral Neovascular Age-Related Macular Degeneration: Multi-Country Observational Study by Alan F. Cruess & Gergana Zlateva & Xiao Xu & Gisele Soubrane & Daniel Pauleikhoff & Andrew Lotery & Jordi Mones & Ronald Buggage & Caroline Schaefer & Tyler Knight & Thomas F. Goss [Downloadable!] 2008 The Last Decade of Italian Pharmaceutical Policy: Instability or Consolidation? by Giovanni Fattore & Claudio Jommi [Downloadable!] 2008 Dynamic Modelling of Infectious Diseases: An Application to the Economic Evaluation of Influenza Vaccination by Roberto Pradas-Velasco & Fernando Antonanzas-Villar & Maria Puy Martinez-Zarate [Downloadable!] 2008 Carmustine Implants for the Treatment of Newly Diagnosed High-Grade Gliomas: A Cost-Utility Analysis by Gabriel Rogers & Ruth Garside & Stuart Mealing & Martin Pitt & Rob Anderson & Matthew Dyer & Ken Stein & Margaret Somerville [Downloadable!] 2008 Cost-Effectiveness Analyses of Hepatitis A Vaccine: A Systematic Review to Explore the Effect of Methodological Quality on the Economic Attractiveness of Vaccination Strategies by Andrea M. Anonychuk & Andrea C. Tricco & Chris T. Bauch & Ba' Pham & Vladimir Gilca & Bernard Duval & Ava John-Baptiste & Gloria Woo & Murray Krahn [Downloadable!] 2008 The New Myth: The Social Value of the QALY by Werner Brouwer & Job van Exel & Rachel Baker & Cam Donaldson [Downloadable!] 2008 An Italian Chart for Cardiovascular Risk Estimate Including High-Density Lipoprotein-Cholesterol by Alessandro Menotti & Mariapaola Lanti [Downloadable!] 2008 Clinical and Economic Effects of a Therapeutic Substitution Policy for Proton Pump Inhibitors in Aboriginal Patients in Northern Communities in Canada by Kathryn Gaebel & Neda Toeg & Mitchell Levine [Downloadable!] 2008 Why it Pays for Hospitals to Initiate a Heart Failure Disease Management Program by Mauricio Velez & Bethany Westerfeldt & Peter S. Rahko [Downloadable!] 2008 Creating the Virtual Team: Application to Diabetes Mellitus Disease Management by Roger Mazze [Downloadable!] 2008 Pharmacist-Led Interventions for the Management of Cardiovascular Disease: Opportunities and Obstacles by Karen J. McConnell & Anne M. Denham & Kari L. Olson [Downloadable!] 2008 Considerations in Culturally Directed Asthma Disease Management Programs by Michelle M. Cloutier [Downloadable!] 2008 Employee Disease Management in US and Global Workplaces: Integrating Strategies and Expanding their Scope by Robin C. Rager & Joseph A. Leutzinger & Jeff A. Hochberg & Wolf Kirsten & David H. Chenoweth [Downloadable!] 2008 The Potential and Pitfalls of Medicine Management: What Have We Learned So Far? by Alison Blenkinsopp & Christine M. Bond [Downloadable!] 2008 Lessons from Early Experience with Pay for Performance by Tim Doran [Downloadable!] 2008 Disease Management Update by Adis International Limited [Downloadable!] 2008 Intensified Diabetes Care Monitoring and Physician Education: Impact on Outcomes and Costs of Care by Ann Donnelly & Prasad Kommareddi & Michael James & Jerry Van Horn & Christopher Zacker & Dan Belletti [Downloadable!] 2008 Cost Analysis of a Maternity Disease Management Program by Gary Stanziano & Niki Istwan [Downloadable!] 2008 Interdisciplinary Coordination for Breast Healthcare: A Rational Approach to Detection, Diagnosis, and Treatment by Benjamin O. Anderson & Cary S. Kaufman & Krystyna D. Kiel & Robert W. Carlson [Downloadable!] 2008 Disease Management Update by Adis International Limited [Downloadable!] 2008 Nursing Workload Associated with Hospital Patient Care by Nicole Mittmann & Soo Jin Seung & Luca F. Pisterzi & Pierre K. Isogai & Donna Michaels [Downloadable!] 2008 General Pain and Frequency of Medical Visits in Family Medicine: A Retrospective Analysis of Medical Records by James E. Rohrer & Stephen P. Merry & Steven C. Adamson & Darryl E. Barnes [Downloadable!] 2008 Challenges and Applications of the Transtheoretical Model in Patients with Diabetes Mellitus by Ana Andres & Juana Gomez & Carmina Saldana [Downloadable!] 2008 Poor Adherence to Medication in Adults with Rheumatoid Arthritis: Reasons and Solutions by Rachel A. Elliott [Downloadable!] 2008 Challenges Facing Nurse-Led Disease Management for Heart Failure by Paul L. Hebert & Jane E. Sisk [Downloadable!] 2007 Verknüpfung von Befragungs- und Prozessdaten : Selektivität durch fehlende Zustimmung der Befragten? by Hartmann, Josef & Krug, Gerhard [Downloadable!] 2007 The Authors by Dominic P. Tilden & Segundo Mariz & Gillies OBryan-Tear & Julia Bottomley & Alexander Diamantopoulos [Downloadable!] 2007 A Lifetime Modelled Economic Evaluation Comparing Pioglitazone and Rosiglitazone for the Treatment of Type 2 Diabetes Mellitus in the UK by Philip Home & Adrian Bagust & Matthew Taylor & Philip Ambery & Samara Mendes da Costa [Downloadable!] 2007 Reliability of Medicaid Claims Versus Medical Record Data: In a Cost Analysis of Palivizumab by Julie Jacobson Vann & John Feaganes & Steven Wegner [Downloadable!] 2007 Preferences of Community Pharmacists for Extended Roles in Primary Care: A Survey and Discrete Choice Experiment by Anthony Scott & Christine Bond & Jackie Inch & Aileen Grant [Downloadable!] 2007 Long-Term Clopidogrel Therapy in Patients Receiving Percutaneous Coronary Intervention by Bart M.S. Heeg & Ron J.G. Peters & Marc Botteman & Ben A. van Hout [Downloadable!] 2007 Epidemiology and Economic Impact of Meticillin-Resistant Staphylococcus aureus: Review and Analysis of the Literature by Andrew F. Shorr [Downloadable!] 2007 Modelling Disease Progression in Alzheimer by Colin Green [Downloadable!] 2007 The Increasingly Complex Fourth Hurdle for Pharmaceuticals by Joshua Cohen & Elly Stolk & Maartje Niezen [Downloadable!] 2007 Measuring Health Preferences for Use in Cost-Utility and Cost-Benefit Analyses of Interventions in Children: Theoretical and Methodological Considerations by Lisa A. Prosser & James K. Hammitt & Ron Keren [Downloadable!] 2007 A 1-Year Prospective Cost-Effectiveness Analysis of Roflumilast for the Treatment of Patients with Severe Chronic Obstructive Pulmonary Disease by Maureen P.M.H. Rutten-van Molken & Floortje E. van Nooten & Marion Lindemann & Manfred Caeser & Peter M.A. Calverley [Downloadable!] 2007 A Stated Preference Binary Choice Experiment to Explore NICE Decision Making by Paul Tappenden & John Brazier & Julie Ratcliffe & James Chilcott [Downloadable!] 2007 Direct Costs in Patients Hospitalised with Community-Acquired Pneumonia After Non-Response to Outpatient Treatment with Macrolide Antibacterials in the US by Joseph A. Paladino & Martin H. Adelman & Jerome J. Schentag & Paul B. Iannini [Downloadable!] 2007 Healthcare Utilisation and Costs Associated with Adding Montelukast to Current Therapy in Patients with Mild to Moderate Asthma and Co-Morbid Allergic Rhinitis: PRAACTICAL Study by Roberto Dal Negro & Peter Piskorz & Roberto Vives & Magda Guilera & Vasilisa Sazonov Kocevar & Xavier Badia [Downloadable!] 2007 The Contrast and Convergence of Bayesian and Frequentist Statistical Approaches in Pharmacoeconomic Analysis by Grant H. Skrepnek [Downloadable!] 2007 Impact of Pharmaceutical Prior Authorisation Policies: A Systematic Review of the Literature by Jaume Puig-Junoy & Ivan Moreno-Torres [Downloadable!] 2007 When Drugs Don't Work: Economic Assessment of Enhancing Compliance with Interventions Supported by Electronic Monitoring Devices by Dyfrig Hughes [Downloadable!] 2007 Cost-Utility Analysis in China: Differences and Difficulties Compared with Developed Countries by Liu Bao Peng & Chong Qing Tan & Xiao Min Wan & Wei Cui [Downloadable!] 2007 Direct and Indirect Costs Attributable to Alcohol Consumption in Germany by Alexander Konnopka & Hans-Helmut Konig [Downloadable!] 2007 The Use of Disease-Specific Outcome Measures in Cost-Utility Analysis: The Development of Dutch Societal Preference Weights for the FACT-L Scale by Leida M. Lamers & Carin A. Uyl-de Groot & Ivonne Buijt [Downloadable!] 2007 A Cost-Effectiveness Analysis of First-Line Controller Therapies for Persistent Asthma by Ya-Chen Tina Shih & Josephine Mauskopf & Rohit Borker [Downloadable!] 2007 Retrospective Economic and Outcomes Analyses Using Non-US Databases: A Review by Lizheng Shi & Eric Q Wu & Meredith Hodges & Andrew Yu & Howard Birnbaum [Downloadable!] 2007 Cost Considerations in the Treatment of Colorectal Cancer by Frank G.A. Jansman & Maarten J. Postma & Jacobus R.B.J. Brouwers [Downloadable!] 2007 Perspectives on Dynamic Optimisation and Control Theory in Treating Hyperlipidaemia by John A. Vernon [Downloadable!] 2007 Being Led Down the Wrong Garden PATH: the Importance of Knowledge and Facts for the Crossroads by Ron Goeree & Daria OReilly & Jean-Eric Tarride & Jim Bowen & Gord Blackhouse & Kaitryn Campbell & Rob Hopkins & Morgan Lim & Lisa Patterson [Downloadable!] 2007 Building Bridges Between Academic Research and Policy Formulation: When Costing Less Means Costing More by Amiram Gafni & Stephen Birch [Downloadable!] 2007 Costs and Benefits of Direct-to-Consumer Advertising: The Case of Depression by Adam E. Block [Downloadable!] 2007 Cost Effectiveness of Oseltamivir Treatment for Patients with Influenza-Like Illness Who Are at Increased Risk for Serious Complications of Influenza: Illustration for The Netherlands by Maarten J. Postma & Annoesjka Novak & Huib W.K.F.H. Scheijbeler & Marlene Gyldmark & Marianne L.L. van Genugten & Jan C. Wilschut [Downloadable!] 2007 Treatment Interruptions and Non-Adherence with Imatinib and Associated Healthcare Costs: A Retrospective Analysis among Managed Care Patients with Chronic Myelogenous Leukaemia by Theodore Darkow & Henry J. Henk & Simu K. Thomas & Weiwei Feng & Jean-Francois Baladi & George A. Goldberg & Alan Hatfield & Jorge Cortes [Downloadable!] 2007 A Systematic Review of Economic Evaluation Literature in Thailand: Are the Data Good Enough to be Used by Policy-Makers? by Yot Teerawattananon & Steve Russell & Miranda Mugford [Downloadable!] 2007 Estimation, Power and Sample Size Calculations for Stochastic Cost and Effectiveness Analysis by S.D. Walter & Amiram Gafni & Stephen Birch [Downloadable!] 2007 Reform of Prescription Drug Reimbursement and Pricing in the German Social Health Insurance Market: A Comparison of Three Scenarios by Stefan Gress & Dea Niebuhr & Uwe May & Jurgen Wasem [Downloadable!] 2007 Cost Effectiveness of Trastuzumab in the Adjuvant Treatment of Early Breast Cancer: A Lifetime Model by J. Alasdair Millar & Michael J. Millward [Downloadable!] 2007 Economic Evaluation of Treatment Administration Strategies of Ganciclovir for Cytomegalovirus Retinitis in HIV/AIDS Patients in Thailand: A Simulation Study by Kanlaya Teerawattananon & Saniorn Iewsakul & Chawewan Yenjitr & Somsanguan Ausayakhun & Watanee Yenjitr & Miranda Mugford & Yot Teerawattananon [Downloadable!] 2007 Costs of a Community Pharmacist-Led Medicines Management Service for Patients with Coronary Heart Disease in England: Healthcare System and Patient Perspectives by Anthony Scott & Michela Tinelli & Christine Bond [Downloadable!] 2007 The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD): Responsiveness to Change and English Language Validation by Peter Wahlqvist & Gordon H. Guyatt & David Armstrong & Alessio DeglInnocenti & Diane Heels-Ansdell & Samer El-Dika & Ingela Wiklund & Carlo A. Fallone & Lisa Tanser & Sander Veldhuyzen van Zanten & Peggy Austin & Alan N. Barkun & Naoki Chiba & Holger J. Schunemann [Downloadable!] 2007 Health Utilities Using the EQ-5D in Studies of Cancer by A. Simon Pickard & Caitlyn T. Wilke & Hsiang-Wen Lin & Andrew Lloyd [Downloadable!] 2007 Replace Pharmaceutical Patents Now by Earl L. Grinols & James W. Henderson [Downloadable!] 2007 Book Review by Adis International Limited [Downloadable!] 2007 Therapeutic Use of Granulocyte Colony-Stimulating Factors for Established Febrile Neutropenia: Effect on Costs from a Hospital Perspective by Leon E. Cosler & Adi Eldar-Lissai & Eva Culakova & Nicole M. Kuderer & David Dale & Jeffrey Crawford & Gary H. Lyman [Downloadable!] 2007 Cost Effectiveness of Once-Daily Oral Chelation Therapy with Deferasirox versus Infusional Deferoxamine in Transfusion-Dependent Thalassaemia Patients: US Healthcare System Perspective by Thomas E. Delea & Oleg Sofrygin & Simu K. Thomas & Jean-Francois Baladi & Pradyumna D. Phatak & Thomas D. Coates [Downloadable!] 2007 Pharmacoeconomics of Available Treatment Options for Metastatic Prostate Cancer by Steven B. Zeliadt & David F. Penson [Downloadable!] 2007 The Economic Implications of Glaucoma: A Literature Review by Jordana K. Schmier & Michael T. Halpern & Mechelle L. Jones [Downloadable!] 2007 Measuring Patient-Reported Outcomes in Solid Organ Transplant Recipients: An Overview of Instruments Developed to Date by Irina Cleemput & Fabienne Dobbels [Downloadable!] 2007 Letter From the Commissioner by John A. Vernon [Downloadable!] 2007 Modelling Cost Effectiveness of Insulin Glargine for the Treatment of Type 1 and 2 Diabetes in Canada by Daniel T. Grima & Melissa F. Thompson & Luc Sauriol [Downloadable!] 2007 Cost Effectiveness of an Adherence-Improving Programme in Hypertensive Patients by Danielle E.M. Brunenberg & Gwenn E.C. Wetzels & Patricia J. Nelemans & Carmen D. Dirksen & Johan L. Severens & Henri E.J.H. Stoffers & Jan S.A.G. Schouten & Martin H. Prins & Peter W. de Leeuw & Manuela A. Joore [Downloadable!] 2007 Recombinant Erythropoietin for Chemotherapy-Related Anaemia: Economic Value and Health-Related Quality-of-Life Assessment Using Direct Utility Elicitation and Discrete Choice Experiment Methods by Diego F. Ossa & Andrew Briggs & Emma McIntosh & Warren Cowell & Tim Littlewood & Mark Sculpher [Downloadable!] 2007 Do Drugs Reduce Utilisation of Other Healthcare Resources? by Pierre-Yves Cremieux & Pierre Ouellette & Patrick Petit [Downloadable!] 2007 Enzyme Replacement Therapy in Orphan and Ultra-Orphan Diseases: The Limitations of Standard Economic Metrics as Exemplified by Fabry-Anderson Disease by David F. Moore & Markus Ries & Evelyn L. Forget & Raphael Schiffmann [Downloadable!] 2007 Economic Evaluations of Cholesterol-Lowering Drugs: A Critical and Systematic Review by Pearl D. Gumbs & Monique W.M. Verschuren & Aukje K. Mantel-Teeuwisse & Ardine G. de Wit & Anthonius de Boer & Olaf H. Klungel [Downloadable!] 2007 Economic Evaluation and Decision Making: Reimbursing Trastuzumab in Early-Stage Breast Cancer by Steven Simoens [Downloadable!] 2007 Measuring Preferences for Cost-Utility Analysis: How Choice of Method May Influence Decision-Making by Christine M. McDonough & Anna N.A. Tosteson [Downloadable!] 2007 Is Medication Review by Pharmacists of Any Use? by Arnold G. Zermansky & Nick Freemantle [Downloadable!] 2007 Letter From the Commissioner by John A. Vernon [Downloadable!] 2007 Home-Based Medication Review in Older People: Is it Cost Effective? by Margaret Pacini & Richard D. Smith & Edward C.F. Wilson & Richard Holland [Downloadable!] 2007 Acute/Subacute Herpes Zoster: Healthcare Resource Utilisation and Costs in a Group of US Health Plans by Ralph P. Insinga & Robbin F. Itzler & James M. Pellissier [Downloadable!] 2007 Conjoint Analysis of French and German Parents by David Bishai & Roger Brice & Isabelle Girod & Aneta Saleh & Jenifer Ehreth [Downloadable!] 2007 Disease Burden of Overactive Bladder: Quality-of-Life Data Assessed Using ICI-Recommended Instruments by Ramandeep Basra & Con Kelleher [Downloadable!] 2007 A by Tracey H. Sach & Richard D. Smith & David K. Whynes [Downloadable!] 2007 Time Preferences for Health in Northern Tanzania: An Empirical Analysis of Alternative Discounting Models by Bjarne Robberstad & John Cairns [Downloadable!] 2007 Reducing the Societal Burden of Depression: A Review of Economic Costs, Quality of Care and Effects of Treatment by Julie M. Donohue & Harold Alan Pincus [Downloadable!] 2007 Cost Effectiveness of Palivizumab for Respiratory Syncytial Virus Prophylaxis in High-Risk Children: A UK Analysis by Mark J.C. Nuijten & Wolfgang Wittenberg & Maximilian Lebmeier [Downloadable!] 2007 A Lifetime Modelled Economic Evaluation Comparing Pioglitazone and Rosiglitazone for the Treatment of Type 2 Diabetes Mellitus in the UK by Dominic P. Tilden & Segundo Mariz & Gillies O'Bryan-Tear & Julia Bottomley & Alexander Diamantopoulos [Downloadable!] 2007 Rates and Probabilities in Economic Modelling: Transformation, Translation and Appropriate Application by Rachael L. Fleurence & Christopher S. Hollenbeak [Downloadable!] 2007 Cost Effectiveness of a Pharmacy-Based Coaching Programme to Improve Adherence to Antidepressants by Judith E. Bosmans & Oscar H. Brook & Hein P.J. van Hout & Martine C. de Bruijne & Hugo Nieuwenhuyse & Lex M. Bouter & Wim A.B. Stalman & Maurits W. van Tulder [Downloadable!] 2007 Letter From the Commissioner's Office at the US FDA by John A. Vernon [Downloadable!] 2007 NICE Cost-Effectiveness Appraisal of Cholinesterase Inhibitors: Was the Right Question Posed? Were the Best Tools Used? by Denis Getsios & Kristen Migliaccio-Walle & Jaime J. Caro [Downloadable!] 2007 When NICE Says No! by Alan Haycox [Downloadable!] 2007 Acknowledgement by Adis International Limited [Downloadable!] 2007 Oral Antiplatelet Therapy in Secondary Prevention of Cardiovascular Events: An Assessment from the Payer by Bart Heeg & Joep Damen & Ben Van Hout [Downloadable!] 2007 Economic Evidence at the Local Level: Options for Making it More Useful by Kees van Gool & Gisselle Gallego & Marion Haas & Rosalie Viney & Jane Hall & Robyn Ward [Downloadable!] 2007 Atorvastatin: A Pharmacoeconomic Review of its Use in the Primary and Secondary Prevention of Cardiovascular Events by Greg L. Plosker & Katherine A. Lyseng-Williamson [Downloadable!] 2007 Recombinant Factor VIIa (Eptacog Alfa): A Pharmacoeconomic Review of its Use in Haemophilia in Patients with Inhibitors to Clotting Factors VIII or IX by Katherine A. Lyseng-Williamson & Greg L. Plosker [Downloadable!] 2007 The Economic Impact of Introducing Serotonin-Noradrenaline Reuptake Inhibitors into the Brazilian National Drug Formulary: Cost-Effectiveness and Budget-Impact Analyses by Marcio Machado & Michael Iskedjian & Ines A. Ruiz & Thomas R. Einarson [Downloadable!] 2007 Cost Effectiveness of Entecavir versus Lamivudine with Adefovir Salvage in HBeAg-Positive Chronic Hepatitis B by David L. Veenstra & Sean D. Sullivan & Lauren Clarke & Uche H. Iloeje & Eskinder Tafesse & Adrian Di Bisceglie & Kris V. Kowdley & Robert G. Gish [Downloadable!] 2007 Strategies for the Management of Suspected Heparin-Induced Thrombocytopenia: A Cost-Effectiveness Analysis by Amanda R. Patrick & Wolfgang C. Winkelmayer & Jerry Avorn & Michael A. Fischer [Downloadable!] 2007 Economic Evaluations of Calcineurin Inhibitors in Renal Transplantation: A Literature Review by Alec H. Miners & Guiqing Yao & James Raftery & Rod S. Taylor [Downloadable!] 2007 The Cost Effectiveness of Bisphosphonates for the Prevention and Treatment of Osteoporosis: A Structured Review of the Literature by Rachael L. Fleurence & Cynthia P. Iglesias & Jeanene M. Johnson [Downloadable!] 2007 It's Time to Choose the Study Design!: Net Benefit Analysis of Alternative Study Designs to Acquire Information for Evaluation of Health Technologies by Oren Shavit & Moshe Leshno & Assaf Goldberger & Amir Shmueli & Amnon Hoffman [Downloadable!] 2007 Warfarin Pharmacogenetics: Economic Considerations by Dyfrig A. Hughes & Munir Pirmohamed [Downloadable!] 2007 Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injections of Insulin: Economic Comparison in Adult and Adolescent Type 1 Diabetes Mellitus in Australia by Neale Cohen & Michael E. Minshall & Lyn Sharon-Nash & Katerina Zakrzewska & William J. Valentine & Andrew J. Palmer [Downloadable!] 2007 Cost Effectiveness of Pegaptanib for the Treatment of Age-Related Macular Degeneration in the UK by Sorrel E. Wolowacz & Neil Roskell & Steven Kelly & Fiona M. Maciver & Chris S. Brand [Downloadable!] 2007 Use of Bayesian Net Benefit Regression Model to Examine the Impact of Generic Drug Entry on the Cost Effectiveness of Selective Serotonin Reuptake Inhibitors in Elderly Depressed Patients by Ya-Chen Tina Shih & Nebiyou B. Bekele & Ying Xu [Downloadable!] 2007 A Comparison of the Cost Effectiveness of Pharmacotherapy or Surgery (Laparoscopic Fundoplication) in the Treatment of GORD by Laura Bojke & Edward Hornby & Mark Sculpher [Downloadable!] 2007 Valuing Children by Joseph A. Ladapo & Peter J. Neumann & Ron Keren & Lisa A. Prosser [Downloadable!] 2007 Lessons from Trial-Based Cost-Effectiveness Analyses of Mental Health Interventions: Why Uncertainty About the Outcome, Estimate and Willingness to Pay Matters by Jeffrey S. Hoch & Carolyn S. Dewa [Downloadable!] 2007 Ninth Annual Disease Management Leadership Forum and First Disease Management Association of America-National Association of Manufacturers Integrated Care Summit: Las Vegas, Nevada, 16-19 September 2007 by Ginny-Louise MacKay [Downloadable!] 2007 Cost-Effectiveness Analysis of a Pharmacy Asthma Care Program in Australia by Adam Gordois & Carol Armour & Martha Brillant & Sinthia Bosnic-Anticevich & Deborah Burton & Lynne Emmerton & Ines Krass & Bandana Saini & Lorraine Smith & Kay Stewart [Downloadable!] 2007 Nurse Practitioner-Based Diabetes Care Management: Impact of Telehealth or Telephone Intervention on Glycemic Control by Karen Chang & Rita Davis & Judy Birt & Pete Castelluccio & Peter Woodbridge & David Marrero [Downloadable!] 2007 Patient and Physician Factors Contributing to Poor Outcomes in Patients with Asthma and COPD by Adrian Gillissen & Hubertus Wirtz & Uwe Juergens [Downloadable!] 2007 Health Support of People with Disabilities in South Australia: Innovations in Policy and Practice by David Caudrey & Marguerite Dissinger [Downloadable!] 2007 Disease Management of Chronic Heart Failure in the Elderly: Issues and Options by Ken McDonald [Downloadable!] 2007 Acknowledgment by Adis International Limited [Downloadable!] 2007 Disease Management Update by Adis International Limited [Downloadable!] 2007 Consensus Development and Application of ICD-9-CM Codes for Defining Chronic Illnesses and their Complications by Ariel Linden & Thomas J. Biuso & Gopal Allada & Alan F. Barker & Joaquin Cigarroa & Sai Praveen Haranath & Diana Rinkevich & Karl Stajduhar [Downloadable!] 2007 Obesity and Medical Visits in Family Medicine: A Retrospective Analysis of Medical Records by James E. Rohrer & Steven C. Adamson & Joseph W. Furst [Downloadable!] 2007 Health Coaching as an Intervention in Health Management Programs by Susan W. Butterworth & Ariel Linden & Wende McClay [Downloadable!] 2007 Selection of Proton Pump Inhibitors for Formulary Inclusion: Making Decisions Based on Appropriate Criteria by Stephen W. Nissen & Keith M. Olsen [Downloadable!] 2007 Health Plan Employer Data and Information Set (HEDIS(R)) Criteria to Determine the Quality of Asthma Care in Children: What Are the Limitations? by Harold J. Farber & Michael Schatz [Downloadable!] 2007 Perspectives on Premenstrual Syndrome/Premenstrual Dysphoric Disorder: Outcomes From a Meeting of the Latin America Experts Group by Luis Bahamondes & Santiago Cordova-Eguez & Jose Enrique Pons & Lee Shulman [Downloadable!] 2007 Disease Management Update by Adis International Limited [Downloadable!] 2007 The Role of Medication Adherence as a Determinant of Blood Pressure Control in a Managed Care Population by Nilay D. Shah & MaryAnn E. Steiner & Lee C. Vermeulen & Lawrence A. Fleming & Patrick R. Cory [Downloadable!] 2007 Consumer-Directed Health Plans and the Chronically Ill by Stephen T. Parente & Jon B. Christianson & Roger Feldman [Downloadable!] 2007 Measuring the Quality of Healthcare: The Connection between Structure, Process, and Outcomes of Care, Using the Example of Myocardial Infarction Treatment in Germany by Ansgar Wubker [Downloadable!] 2007 Evaluation of an Online Relapse Prevention Program for Bipolar Disorder: An Overview of the Aims and Methodology of a Randomized Controlled Trial by Caryl Barnes & Robin Harvey & Philip Mitchell & Michael Smith & Kay Wilhelm [Downloadable!] 2007 Physician-Patient e-Visit Programs: Implementation and Appropriateness by Pamela Whitten & Lorraine Buis & Brad Love [Downloadable!] 2007 Disease Management Programs for Glaucoma: Has the Vision Become a Reality? by Lawrence D. Goldberg [Downloadable!] 2007 Disease Management Update by Adis International Limited [Downloadable!] 2007 Psychoeducational Approaches to Medication Adherence in Patients with Bipolar Disorder by Martha Sajatovic & Peijun Chen & Philipp Dines & Edwin R. Shirley [Downloadable!] 2007 Treating Allergic Asthma with Omalizumab by Paul P. Belliveau & Monina R. Lahoz [Downloadable!] 2007 Design, Measurement, and Evaluation of an Education Strategy in the Hospital Setting to Combat Antimicrobial Resistance: Theoretical Considerations and a Practical Example by Celine Pulcini & Sally Crofts & Diane Campbell & Peter Davey [Downloadable!] 2007 Implementation of an HPV-Vaccination Program: Key Factors for Success by Shalini L. Kulasingam [Downloadable!] 2007 Disease Management and the Medical Home Model: Competing or Complementary? by Vincent Kuraitis [Downloadable!] 2007 Abandoning the UK NHS? by Tony Clive Hockley [Downloadable!] 2007 The Role of Spirometry in Evaluating Therapeutic Responses in Advanced COPD by Pierantonio Laveneziana & Denis E. ODonnell [Downloadable!] 2007 The Rise of Specialty Pharmacy Costs: Issues for Providers, Payers, and Patients by Steve B. Miller & Tracy A. Hoffman & Jonah C. Houts & Jane L. Miller & Britton L. Pim & Andrew Behm [Downloadable!] 2007 Exploring Disease Management Programs for Diabetes Mellitus: Proposal of a Novel Hybrid Model by Kerri L. Cavanaugh & Richard O. White & Russell L. Rothman [Downloadable!] 2007 Physician Prescribing and Medicare Part D: Closing the Gaps by William H. Shrank [Downloadable!] 2007 Disease Management Update by Adis International Limited [Downloadable!] 2007 Patient-Motivated Prevention of Lifestyle-Related Disease in Japan: A Randomized, Controlled Clinical Trial by Akira Babazono & Chihoko Kame & Reiko Ishihara & Eiji Yamamoto & Alan L. Hillman [Downloadable!] 2007 Techniques for Measuring Medication Adherence in Hypertensive Patients in Outpatient Settings: Advantages and Limitations by Jay Hawkshead & Marie A. Krousel-Wood [Downloadable!] 2007 Initiatives to Promote Effective Self-Care Skills in Children and Adolescents with Diabetes Mellitus by Barbara J. Anderson & Britta Svoren & Lori Laffel [Downloadable!] 2007 Estimating the Effect of Regression to the Mean in Health Management Programs by Ariel Linden [Downloadable!] 2007 Disease Management Update by Adis International Limited [Downloadable!] 2007 Spotlight on the Pharmacoeconomics of Candesartan Cilexetil in Chronic Heart Failure and Hypertension by Greg L. Plosker & Susan J. Keam [Downloadable!] 2007 The Impact of Nebulized Levalbuterol on Health Care Payments for Elderly Asthma and Chronic Obstructive Pulmonary Disease Patients in Medicaid Plans by Ronald J. Ozminkowski & Shaohung Wang & Stacey R. Long [Downloadable!] 2007 Estimating the Impact of a Congestive Heart Failure Disease Management Program on Prescription Drug Use: A State Medicaid Program by Anthony C. Moscoso & Matthew J. Strand & Gregory D. Berg & Gary K. Grunwald [Downloadable!] 2007 Hypertension Home Telemonitoring: Current Evidence and Recommendations for Future Studies by Mirou Jaana & Guy Pare & Claude Sicotte [Downloadable!] 2007 Use of the Pre-Post Method to Measure Cost Savings in Disease Management: Issues and Implications by Ariel Linden [Downloadable!] 2007 Initiatives and Barriers to Adopting Health Information Technology: A US Perspective by Henry A. DePhillips [Downloadable!] 2006 Why evolution does not always lead to an optimal proto-language.An approach based on the replicator dynamics by Christina Pawlowitsch [Downloadable!] 2006 Principle of Uncertain Future by Alexander Harin [Downloadable!] 2006 A Rational Irrational Man? by Alexander Harin [Downloadable!] 2006 Competition as a Socially Desirable Dilemma by Christoph Engel [Downloadable!] 2006 Multivariate and Multicriteria Evaluation of Labour Market Situation by Monika Sedenkova & Jiri Horak [Downloadable!] 2006 The Authors by Adrian A. Bagust & Marc Evans & Sophie Beale & Philip Home & Andrew Perry & Murray Stewart & Arran Shearer & Alan Martin & Lisa Hulme & Andreas Liebl & Oliver Schoeffski & Anita Goertz & Javier Ampudia-Blasco & Belen Martinez-Lage & Isabel Perez Escolano & Gonzalo Paris [Downloadable!] 2006 Modelling Lifetime Metabolic Progression and Cost Effectiveness of Treatment Strategies for Type 2 Diabetes by Andrew J. Palmer & Craig J. Currie [Downloadable!] 2006 Missing Data Imputation in Quality-of-Life Assessment: Imputation for WHOQOL-BREF by Ting Hsiang Lin [Downloadable!] 2006 Public Funding of Bosentan for the Treatment of Pulmonary Artery Hypertension in Australia: Cost Effectiveness and Risk Sharing by John H. Wlodarczyk & Leslie G. Cleland & Anne M. Keogh & Keith D. McNeil & Kate Perl & Robert G. Weintraub & Trevor J. Williams [Downloadable!] 2006 Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996-2003 by Yue-Chune Lee & Ming-Chin Yang & Yu-Tung Huang & Chien-Hsiang Liu & Sun-Bing Chen [Downloadable!] 2006 Cost-of-Illness Studies: A Review of Current Methods by Ebere Akobundu & Jing Ju & Lisa Blatt & C. Daniel Mullins [Downloadable!] 2006 Using Discrete Choice Experiments within a Cost-Benefit Analysis Framework: Some Considerations by Emma McIntosh [Downloadable!] 2006 The Value of Thinly Spread QALYs by Duncan Mortimer [Downloadable!] 2006 Accuracy versus Transparency in Pharmacoeconomic Modelling: Finding the Right Balance by David M. Eddy [Downloadable!] 2006 US FDA Guidance: Apropos of PROs by Paul Kind [Downloadable!] 2006 National-Level Purchasing of Expensive Drugs is Increasing Pressure on the Hospital Drug Budget by Slobodan M. Jankovic & Nebojsa Milivojevic [Downloadable!] 2006 Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at Cholesterol Treatment Goal in Canada by Michele Kohli & Cheryl Attard & Annette Lam & Daniel Huse & John Cook & Chantal Bourgault & Evo Alemao & Donald Yin & Michael Marentette [Downloadable!] 2006 Costs of Inflammatory Bowel Disease in Germany by Renee Stark & Hans-Helmut Konig & Reiner Leidl [Downloadable!] 2006 A Multi-Country Health Economic Evaluation of Highly Concentrated N-3 Polyunsaturated Fatty Acids in Secondary Prevention after Myocardial Infarction by Mark Lamotte & Lieven Annemans & Pawel Kawalec & York Zoellner [Downloadable!] 2006 Pharmacoeconomic Analyses of Azathioprine, Methotrexate and Prospective Pharmacogenetic Testing for the Management of Inflammatory Bowel Disease by Virginia L. Priest & Evan J. Begg & Sharon J. Gardiner & Christopher M.A. Frampton & Richard B. Gearry & Murray L. Barclay & David W.J. Clark & Paul Hansen [Downloadable!] 2006 A Comparative Review of Health-Related Quality-of-Life Measures for Use in HIV/AIDS Clinical Trials by Darren J. Clayson & Diane J. Wild & Paul Quarterman & Isabelle Duprat-Lomon & Maria Kubin & Stephen Joel Coons [Downloadable!] 2006 Prostaglandin Analogues for the Treatment of Glaucoma and Ocular Hypertension: A Systematic Review of Economic Evidence by Michelle Orme & Annabel Boler [Downloadable!] 2006 Cost Effectiveness of Leukotriene Modifiers in Adults with Asthma by Pamela C. Heaton [Downloadable!] 2006 Clopidogrel: A Pharmacoeconomic Review of its Use in Patients with Non-ST Elevation Acute Coronary Syndromes by Katherine A. Lyseng-Williamson & Greg L. Plosker [Downloadable!] 2006 Cost Effectiveness of Budesonide/Formoterol for Maintenance and Reliever Therapy versus Salmeterol/Fluticasone plus Salbutamol in the Treatment of Asthma by Gunnar Johansson & Emma B. Andreasson & Per E. Larsson & Claus F. Vogelmeier [Downloadable!] 2006 Tapering Off Benzodiazepines in Long-Term Users: An Economic Evaluation by Richard C. Oude Voshaar & Paul F.M. Krabbe & Wim J.M.J. Gorgels & Eddy M.M. Adang & Anton J.L.M. van Balkom & Eloy H. van de Lisdonk & Frans G. Zitman [Downloadable!] 2006 Usefulness of the Audit of Diabetes-Dependent Quality-of-Life (ADDQoL) Questionnaire in Patients with Diabetes in a Multi-Ethnic Asian Country by Hwee-Lin Wee & Chee-Eng Tan & Su-Yen Goh & Shu-Chuen Li [Downloadable!] 2006 Hepatitis C: Cost of Illness and Considerations for the Economic Evaluation of Antiviral Therapies by John B. Wong [Downloadable!] 2006 Cost of Lung Cancer: A Methodological Review by Laurent Molinier & Christophe Combescure & Cristos Chouaid & Jean-Pierre Daures & Bruno Housset & Didier Fabre & Alain Grand & Alain Vergnenegre [Downloadable!] 2006 Developing Health-Related Quality-of-Life Instruments for Use in Asia: The Issues by Yin Bun Cheung & Julian Thumboo [Downloadable!] 2006 Economic Models of Antiretroviral Therapy: Searching for the Optimal Strategy by Fred J. Hellinger [Downloadable!] 2006 NICE Says No to Inhaled Insulin: What Lessons Should We Learn? by Nick Freemantle [Downloadable!] 2006 The Authors by Colin Green & Joanna Picot & Emma Loveman & Andrea Takeda & Jo Kirby & Andrew Clegg [Downloadable!] 2006 Modelling the Cost Effectiveness of Cholinesterase Inhibitors in the Management of Mild to Moderately Severe Alzheimer by Nick Bosanquet & Andrew Yeates [Downloadable!] 2006 Is the Childhood Asthma Questionnaire a Good Measure of Health-Related Quality of Life of Asthmatic Children in Asia?: Validation Among Paediatric Patients with Asthma in Singapore by Lee-Yee Chong & Oh-Moh Chay & Li Shu-Chuen [Downloadable!] 2006 Dalteparin versus Warfarin for the Prevention of Recurrent Venous Thromboembolic Events in Cancer Patients: A Pharmacoeconomic Analysis by George Dranitsaris & Mark Vincent & Mark Crowther [Downloadable!] 2006 Cost Effectiveness of Enoxaparin as Prophylaxis against Venous Thromboembolic Complications in Acutely Ill Medical Inpatients: Modelling Study from the Hospital Perspective in Germany by Peter K. Schadlich & Michael Kentsch & Manfred Weber & Wolfgang Kammerer & Josef Georg Brecht & Vijay Nadipelli & Eduard Huppertz [Downloadable!] 2006 The Effects of Type 1 Diabetes and its Long-Term Complications on Physical and Mental Health Status by Jarmo Hahl & Helena Hamalainen & Tuula Simell & Olli Simell [Downloadable!] 2006 The Impact of Losartan on the Lifetime Incidence of End-Stage Renal Disease and Costs in Patients with Type 2 Diabetes and Nephropathy by George W. Carides & Shahnaz Shahinfar & Erik J. Dasbach & William F. Keane & William C. Gerth & Charles M. Alexander & William H. Herman & Barry M. Brenner & the RENAAL Investigators [Downloadable!] 2006 Healthcare Rationing in Spain: Framework, Descriptive Analysis and Consequences by Rosa Rodriguez-Monguio & Fernando Antonanzas Villar [Downloadable!] 2006 Pharmacoeconomics of Angiotensin II Antagonists in Type 2 Diabetic Patients with Nephropathy: Implications for Decision Making by Cornelis Boersma & Jarir Atthobari & Ron T. Gansevoort & Lolkje T.W. de Jong-Van den Berg & Paul E. de Jong & Dick de Zeeuw & Lieven J.P. Annemans & Maarten J. Postma [Downloadable!] 2006 The Authors' Reply by Lawrence D. Goldberg & John G. Walt [Downloadable!] 2006 Cost Considerations in the Medical Management of Glaucoma in the US: Estimated Yearly Costs and Cost Effectiveness of Bimatoprost Compared with Other Medications by Javier Soto [Downloadable!] 2006 Letrozole: A Pharmacoeconomic Review of its Use in Postmenopausal Women with Breast Cancer by Christopher Dunn & Susan J. Keam [Downloadable!] 2006 Economic Evaluation of Weekly Epoetin Alfa versus Biweekly Darbepoetin Alfa for Chemotherapy-Induced Anaemia: Evidence from a 16-Week Randomised Trial by Shelby D. Reed & Jasmina I. Radeva & Davey B. Daniel & Samir H. Mody & Jamie B. Forlenza & R. Scott McKenzie & Kevin A. Schulman [Downloadable!] 2006 Comprehensive Decision-Analytic Model and Bayesian Value-of-Information Analysis: Pentoxifylline in the Treatment of Chronic Venous Leg Ulcers by Cynthia P. Iglesias & Karl Claxton [Downloadable!] 2006 Encouraging Smokers to Quit: The Cost Effectiveness of Reimbursing the Costs of Smoking Cessation Treatment by Janneke Kaper & Edwin J. Wagena & Constant P. van Schayck & Johan L. Severens [Downloadable!] 2006 Cost Effectiveness of Increasing the Dose Intensity of Chemotherapy with Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer: Based on Data from the Medical Research Council LU19 Trial by Laura Bojke & Mark Sculpher & Richard Stephens & Wendi Qian & Nick Thatcher & David Girling [Downloadable!] 2006 Cost Effectiveness of Preventive Interventions in Type 2 Diabetes Mellitus: A Systematic Literature Review by Sylvia M.C. Vijgen & Mirjam Hoogendoorn & Caroline A. Baan & G. Ardine de Wit & Wien Limburg & Talitha L. Feenstra [Downloadable!] 2006 Accounting for Tastes: A German Perspective on the Inclusion of Patient Preferences in Healthcare by Florian Vogt & David L.B. Schwappach & John F.P. Bridges [Downloadable!] 2006 The Authors by Richard J. Milne & Kathy H. Heaton-Brown & Paul Hansen & David Thomas & Vernon Harvey & Alison Cubitt [Downloadable!] 2006 Quality-of-Life Valuations of Advanced Breast Cancer by New Zealand Women by Stephanie Land [Downloadable!] 2006 Productivity Costs in Health-State Valuations: Does Explicit Instruction Matter? by Marieke Krol & Werner Brouwer & Pedram Sendi [Downloadable!] 2006 A Cost-Utility Analysis of Losartan versus Atenolol in the Treatment of Hypertension with Left Ventricular Hypertrophy by Aslam H. Anis & Huiying Sun & Sonia Singh & John Woolcott & Bohdan Nosyk & Marc Brisson [Downloadable!] 2006 Post-Exposure Influenza Prophylaxis with Oseltamivir: Cost Effectiveness and Cost Utility in Families in the UK by Beate Sander & Frederick G. Hayden & Marlene Gyldmark & Louis P. Garrison [Downloadable!] 2006 Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment: A Review and Consolidation of Quality Assessment by Zoe Philips & Laura Bojke & Mark Sculpher & Karl Claxton & Su Golder [Downloadable!] 2006 Optimal Assignment of Treatments to Health States Using a Markov Decision Model: An Introduction to Basic Concepts by Mohan V. Bala & Josephine A. Mauskopf [Downloadable!] 2006 Economic and Developmental Considerations for Pharmacogenomic Technology by John A. Vernon & Scott J. Johnson & W. Keener Hughen & Antonio Trujillo [Downloadable!] 2006 The Burden of Age-Related Macular Degeneration by Jordana K. Schmier & Mechelle L. Jones & Michael T. Halpern [Downloadable!] 2006 Bernard S. Bloom, PhD by Henry A. Glick [Downloadable!] 2006 Rationing of Drugs for Rare Diseases by Dyfrig Hughes [Downloadable!] 2006 Bimatoprost: A Pharmacoeconomic Review of its Use in Open-Angle Glaucoma and Ocular Hypertension by Greg L. Plosker & Susan J. Keam [Downloadable!] 2006 The Authors' Reply by Paul Kind & Sue Macran [Downloadable!] 2006 Eliciting Social Preference Weights for Functional Assessment of Cancer Therapy-Lung Health States by A. Simon Pickard & Deborah Dobrez & David Cella [Downloadable!] 2006 Quality-of-Life Valuations of Advanced Breast Cancer by New Zealand Women by Richard J. Milne & Kathy H. Heaton-Brown & Paul Hansen & David Thomas & Vernon Harvey & Alison Cubitt [Downloadable!] 2006 Functional Impairment, Healthcare Costs and the Prevalence of Institutionalisation in Patients with Alzheimer's Disease and Other Dementias by Jerrold Hill & Howard Fillit & Simu K. Thomas & Sobin Chang [Downloadable!] 2006 Cost Considerations in the Medical Management of Glaucoma in the US: Estimated Yearly Costs and Cost Effectiveness of Bimatoprost Compared with Other Medications by Lawrence D. Goldberg & John Walt [Downloadable!] 2006 Cost Effectiveness of Extended Adjuvant Letrozole in Postmenopausal Women after Adjuvant Tamoxifen Therapy: The UK Perspective by Jonathan Karnon & Thomas Delea & Stephen R.D. Johnston & Robert Smith & Jane Brandman & Jennifer Sung & Paul E. Goss [Downloadable!] 2006 Trends in Outpatient Prescription Drug Use and Related Costs in the US: 1998-2003 by Diane K. Wysowski & Laura A. Governale & Joslyn Swann [Downloadable!] 2006 Aromatase Inhibitors in Breast Cancer: A Review of Cost Considerations and Cost Effectiveness by Jonathan Karnon [Downloadable!] 2006 Less is More: Medicines that Require Less Frequent Administration Improve Adherence, but Are They Better? by Dyfrig Hughes [Downloadable!] 2006 How Much is the Cost of Visual Impairment: the Author's Reply by Antoine Lafuma [Downloadable!] 2006 How Much is the Cost of Visual Impairment: Caveat Emptor by Catherine Meads & Chris Hyde [Downloadable!] 2006 Evaluation of Non-Medical Costs Associated with Visual Impairment in Four European Countries: France, Italy, Germany and the UK by Antoine Lafuma & Antoine Brezin & Stefania Lopatriello & Klaus Hieke & Julia Hutchinson & Viviane Mimaud & Gilles Berdeaux [Downloadable!] 2006 The Long-Term Cost Effectiveness of Treatments for Benign Prostatic Hyperplasia by Rachael L. DiSantostefano & Andrea K. Biddle & John P. Lavelle [Downloadable!] 2006 A Multi-Country Economic Evaluation of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease by Mark Lamotte & Lieven Annemans & Thomas Evers & Maria Kubin [Downloadable!] 2006 Combination Vaccine Against Invasive Meningococcal B and Pneumococcal Infections: Potential Epidemiological and Economic Impact in The Netherlands by Jasper M. Bos & Hans C. Rumke & Robert Welte & Lodewijk Spanjaard & Loek van Alphen & Maarten J. Postma [Downloadable!] 2006 Differential Effects of Atypical versus Typical Antipsychotic Medication on Earnings of Schizophrenia Patients: Estimates from a Prospective Naturalistic Study by David Salkever & Eric Slade & Mustafa Karakus [Downloadable!] 2006 Sociodemographic Differences in Quality of Life in Rheumatoid Arthritis by Erik J. Groessl & Theodore G. Ganiats & Andrew J. Sarkin [Downloadable!] 2006 Better Analysis for Better Decisions: Has Pharmacoeconomics Come of Age? by Michael Drummond & Mark Sculpher [Downloadable!] 2006 Economic Evaluation of Rivastigmine in Patients with Parkinson's Disease Dementia by Andrew R. Willan & Ron Goeree & Eleanor M. Pullenayegum & Christopher McBurney & Gordon Blackhouse [Downloadable!] 2006 Cost Effectiveness of Bemiparin Sodium versus Unfractionated Heparin and Oral Anticoagulants in the Acute and Long-Term Treatment of Deep Vein Thrombosis by Antonio Gomez-Outes & Eduardo Rocha & Javier Martinez-Gonzalez & Vijay V. Kakkar [Downloadable!] 2006 Evaluation of the Cost Effectiveness of Sirolimus versus Tacrolimus for Immunosuppression Following Renal Transplantation in the UK by Phil McEwan & Simon Dixon & Keshwar Baboolal & Pete Conway & Craig J. Currie [Downloadable!] 2006 Interstitial Cystitis: Cost, Treatment and Co-morbidities in an Employed Population by Eric Q. Wu & Howard Birnbaum & Milena Mareva & Andrew Parece & Zihong Huang & David Mallett & Haya Taitel [Downloadable!] 2006 Incorporating Carer Effects into Economic Evaluation by Simon Dixon & Mel Walker & Sam Salek [Downloadable!] 2006 Too Important to Ignore: Informal Caregivers and Other Significant Others by Werner B.F. Brouwer [Downloadable!] 2006 Costs of Irritable Bowel Syndrome in the UK and US by Stefanie Maxion-Bergemann & Frank Thielecke & Florian Abel & Rito Bergemann [Downloadable!] 2006 Bayesian Methods for Evidence Synthesis in Cost-Effectiveness Analysis by A.E. Ades & Mark Sculpher & Alex Sutton & Keith Abrams & Nicola Cooper & Nicky Welton & Guobing Lu [Downloadable!] 2006 The Authors by J.M. Bos & M.J. Postma & L. Annemans [Downloadable!] 2006 Discounting Health Effects in Pharmacoeconomic Evaluations: Current Controversies by Stuart Birks [Downloadable!] 2006 Candesartan Cilexetil: A Pharmacoeconomic Review of its Use in Chronic Heart Failure and Hypertension by Greg L. Plosker & Susan J. Keam [Downloadable!] 2006 Association of Co-Morbidities with Prescribing Patterns and Cost Savings: Olanzapine versus Risperidone for Schizophrenia by Wei Yu & Xinhua S. Ren & Austin F. Lee & Lawrence Herz & Yu-Hui Huang & Lewis E. Kazis [Downloadable!] 2006 Cost Effectiveness of Tumour Necrosis Factor-alpha Inhibitors as First-Line Agents in Rheumatoid Arthritis by James R. Spalding & Joel Hay [Downloadable!] 2006 Generic Health-Related Quality-of-Life Assessment in Children and Adolescents: Methodological Considerations by Ulrike Ravens-Sieberer & Michael Erhart & Nora Wille & Ralf Wetzel & Jennifer Nickel & Monika Bullinger [Downloadable!] 2006 Assessing Generalisability in Model-Based Economic Evaluation Studies: A Structured Review in Osteoporosis by Hege Urdahl & Andrea Manca & Mark J. Sculpher [Downloadable!] 2006 Letter From the Commissioner's Office at the US FDA by John A. Vernon [Downloadable!] 2006 Do Pharmacogenomic Tests Provide Value to Policy Makers? by Ya-Chen Tina Shih & Lajos Pusztai [Downloadable!] 2006 Acknowledgement by Adis International Limited [Downloadable!] 2006 Economic Evaluation in the US: What is the Missing Link? by Peter J. Neumann & Sean D. Sullivan [Downloadable!] 2006 Economic Evaluations in the Canadian Common Drug Review by Andreas Laupacis [Downloadable!] 2006 Building Bridges Between Academic Research and Policy Formulation: The PRUFE Framework - an Integral Part of Ontario by Ron Goeree & Leslie Levin [Downloadable!] 2006 Economic Evaluation and Decision Making in the UK by Martin J. Buxton [Downloadable!] 2006 Information Created to Evade Reality (ICER): Things We Should Not Look to for Answers by Stephen Birch & Amiram Gafni [Downloadable!] 2006 Conference Paper by Andrea Manca & Andrew R. Willan [Downloadable!] 2006 Analysis Sans Frontieres: Can We Ever Make Economic Evaluations Generalisable Across Jurisdictions? by Mark J. Sculpher & Michael F. Drummond [Downloadable!] 2006 Pharmacoeconomics and Pharmacoepidemiology: Curious Bedfellows or a Match Made in Heaven? by Andrew H. Briggs & Adrian R. Levy [Downloadable!] 2006 Utility Measurement in Healthcare: The Things I Never Got To by George W. Torrance [Downloadable!] 2006 Using Value of Information Analysis to Prioritise Health Research: Some Lessons from Recent UK Experience by Karl P. Claxton & Mark J. Sculpher [Downloadable!] 2006 Recent Developments in Decision-Analytic Modelling for Economic Evaluation by Milton C. Weinstein [Downloadable!] 2006 Better Analysis for Better Decisions: Facing Up to the Challenges by Michael F. Drummond & Mark J. Sculpher [Downloadable!] 2006 Hospitalisation Costs of Cystic Fibrosis by Jonas Schreyogg & Helge Hollmeyer & Miriam Bluemel & Doris Staab & Reinhard Busse [Downloadable!] 2006 Disability and Quality of Life in Post-Traumatic Stress Disorder: Impact of Drug Treatment by Soraya Seedat & Christine Lochner & Bavanisha Vythilingum & Dan J. Stein [Downloadable!] 2006 Single-Inhaler Combination Therapy for Asthma: A Review of Cost Effectiveness by Manabu Akazawa & David A. Stempel [Downloadable!] 2006 Therapeutic Options for the Prevention and Treatment of Postoperative Nausea and Vomiting: A Pharmacoeconomic Review by Jean Lachaine [Downloadable!] 2006 Should We Abandon QALYs as a Resource Allocation Tool? by Sandeep Vijan [Downloadable!] 2006 QALYs: Are They Helpful to Decision Makers? by Maurice McGregor & J. Jaime Caro [Downloadable!] 2006 The Generalisability of Pharmacoeconomic Studies: Issues and Challenges Ahead by James M. Mason & Anne R. Mason [Downloadable!] 2006 Anticoagulation for Stroke Prevention: High Effectiveness, More Cost Benefit? by Eduard Shantsila & Timothy Watson & Gregory Y.H. Lip [Downloadable!] 2006 The Cost Effectiveness of Anticoagulation Management Services for Patients with Atrial Fibrillation and at High Risk of Stroke in the US by Patrick W. Sullivan & Thomas W. Arant & Samuel L. Ellis & Heather Ulrich [Downloadable!] 2006 The Initial Validation of a Markov Model for the Economic Evaluation of (New) Treatments for Rheumatoid Arthritis by Paco M.J. Welsing & Johan L. Severens & Margriet Hartman & Anke M. van Gestel & Piet L.C.M. van Riel & Roland F.J.M. Laan [Downloadable!] 2006 2006 Disease Management Leadership Forum Meeting Report: Denver, Colorado, 2-5 December 2006 by Julie A. Meek [Downloadable!] 2006 Economic Analysis of a Telemedicine Intervention to Improve Glycemic Control in Patients with Diabetes Mellitus: Illustration of a Novel Analytic Method by James M. Mason & Robert J. Young & John P. New & J. Martin Gibson & Andrew F. Long & Tina Gambling & Tim Friede [Downloadable!] 2006 Psychiatric Drug Use Among Patients of a Community Mental Health Service: Patterns and Implications by Natasa Gisev & J. Simon Bell & Andrew J. McLachlan & Manoranjenni Chetty & Timothy F. Chen [Downloadable!] 2006 Combination Therapy for Asthma: Perspectives of the Patient, Provider, and Payer by Harold J. Farber & James Glauber [Downloadable!] 2006 Targeted Screening and Treatment of Chronic Kidney Disease: Lessons Learned from the Kidney Early Evaluation Program by Joseph A. Vassalotti & Leslie Gracz-Weinstein & Monica R. Gannon & Wendy Weinstock Brown [Downloadable!] 2006 Using Nicotine Replacement Therapy to Assist in Reducing Cigarette Consumption before Quitting: Another Strategy for Smoking Cessation? by Hayden McRobbie & Robyn Whittaker & Christopher Bullen [Downloadable!] 2006 Putting a Public Health Face on Clinical Practice: Potential for Using an Infectious Disease Management Model for Chronic Disease Prevention by Donald O. Fedder & Harsha Desai & Migle Maciunskaite [Downloadable!] 2006 Acknowledgment by Adis International Limited [Downloadable!] 2006 Disease Management Update by Adis International Limited [Downloadable!] 2006 The Role of Peginterferon alpha-2a (40kD) Plus Ribavirin in the Management of Chronic Hepatitis C Mono-Infection by Dene Simpson & Monique P. Curran [Downloadable!] 2006 The Impact of Open Access to Atypical Antipsychotics on Treatment Costs for Medi-Cal Patients with Bipolar Disorder by Sangeeta Narayan & Kimberly L. Sterling & Jeffrey S. McCombs [Downloadable!] 2006 Internet-Based Smoking Cessation Initiatives: Availability, Varieties, and Likely Effects on Outcomes by Anna M. McDaniel & Renee M. Stratton [Downloadable!] 2006 Preparing for and Responding to Bioterrorist Attacks: The Role of Disease Management Initiatives by R. Gregory Evans & Steven J. Lawrence [Downloadable!] 2006 Disease Management and Its Implications for Outpatient Physician Practice: A Memo for Physicians by Jaan Sidorov [Downloadable!] 2006 Disease Management Update by Adis International Limited [Downloadable!] 2006 Impact of a Diabetes Disease Management Program by Race and Ethnicity by Verna L. Welch & Natalia Vukshich Oster & Julie A. Gazmararian & Kimberly Rask & Laura Schild & Charles Cutler & Claire Spettell & Michael Reardon [Downloadable!] 2006 Disease Management of the Frail Elderly Population by Stuart Levine & Judy Y. Reyes & Randy Schwartz & Dave Schmidt & Tim Schwab & Moon Leung [Downloadable!] 2006 Poor Adherence to Anti-inflammatory Medication in Asthma: Reasons, Challenges, and Strategies for Improved Disease Management by Rachel A. Elliott [Downloadable!] 2006 Developing a Specialist Patient Program for Migraine by Ann Turner [Downloadable!] 2006 Adherence to Antipsychotic Treatment in Schizophrenia: What Role Does Cognitive Behavioral Therapy Play in Improving Outcomes? by Gary Donohoe [Downloadable!] 2006 Measuring the Economic Value of Disease Management Programs by Don Fetterolf [Downloadable!] 2006 In Search of Financial Savings from Disease Management: Applying the Number-Needed-to-Decrease Analysis to a Diabetic Population by Ariel Linden & Thomas J. Biuso [Downloadable!] 2006 Disease Management Update by Adis International Limited [Downloadable!] 2006 Community Direct Access Service for Early Detection and Treatment of Clinical Deterioration: Effectiveness and Impact on the Workload Pattern of a Hospital-Based Heart Failure Unit by Carmel Conlon & Christina OLoughlin & Mark Ledwidge & Kenneth McDonald [Downloadable!] 2006 Analysis of Factors Affecting Patient Satisfaction: Focus on Asthma Patients by Bayram Sahin & Mehtap Tatar [Downloadable!] 2006 Impact of Telehealth on Healthcare Utilization by Congestive Heart Failure Patients by Craig A. Lehmann & Nancy Mintz & Jean Marie Giacini [Downloadable!] 2006 Evaluation of an Asthma Disease Management Program in a Medicaid Population by Alice Lind & Louise Kaplan & Gregory D. Berg [Downloadable!] 2006 Telemedicine for Diabetes Care by Toree H. Malasanos [Downloadable!] 2006 Removing Prescription Charges for Patients with Mental Health Disorders: Would it Improve Patient Outcomes in the UK? by Ellen I. Schafheutle [Downloadable!] 2006 Physician Voluntary Reporting Program by David W. Plocher [Downloadable!] 2006 The Economic Burden of End-Stage Renal Disease with Hyperphosphatemia: A Study of Florida Medicaid by Annesha White & Folakemi Odedina & Hong Xiao & Ellen Campbell & Richard Segal [Downloadable!] 2006 Process Optimization by Means of a Computerized Process Simulation Model in Cardiac Surgery by Richard Feyrer & Udo Kunzmann & Michael Weyand & Robert Cesnjevar [Downloadable!] 2006 Promoting the Implementation of Best-Practice Guidelines Using a Matrix Tool: Focus on Cancer Care by Karen Luxford & David Hill & Richard Bell [Downloadable!] 2006 Type 2 Diabetes Mellitus Treatment Patterns and Healthcare Costs in the Elderly Population by Gary Erwin & Shrividya Iyer & Rukmini Rajagopalan & James Astuto & Patricia Wilson & Justin Schaneman & Nathan Kleinman [Downloadable!] 2006 Prescription to Over-the-Counter Switch of Second-Generation Antihistamines (Loratadine): A Review of Its Impact on Healthcare Costs and Resource Utilization by Kavita V. Nair [Downloadable!] 2006 Disease Management Update by Adis International Limited [Downloadable!] 2006 Management of Schizophrenia: Defining the Role of Long-Acting Injectable Risperidone by Monique P. Curran & Gillian M. Keating [Downloadable!] 2006 The Cost of Lung Cancer Management in France from the Payor by Alain Vergnenegre & Laurent Molinier & Christophe Combescure & Jean-Pierre Daures & Bruno Housset & Christos Chouaid [Downloadable!] 2006 Population-Based Disease Management in the German Statutory Health Insurance: Implementation and Preliminary Results by Stephanie A.K. Stock & Marcus Redaelli & Karl W. Lauterbach [Downloadable!] 2006 Clinical and Behavioral Impact of Implementing Community-Based Diabetes Disease Management in Japan by Hiroyuki Sakamaki & Shunya Ikeda & Naoki Ikegami & Michiko Norimoto & Shigemitsu Moriwaki [Downloadable!] 2006 An Evaluation of the Factors Associated with Statin Dose Management and Low-Density Lipoprotein-Cholesterol Goal Attainment by Caron Ory & Christina Fontes & Setareh A. Williams & Gerald M. Borok & Kenneth McDonough & Eunice Chang [Downloadable!] 2006 Disease Management for Hypertension: A Pilot Cluster Randomized Trial of 67 Australian General Practices by Deborah A. Turnbull & Justin J. Beilby & Tahereh Ziaian & Farooq Qureshi & Mark Nelson & Anne L. Tonkin & John E. Marley [Downloadable!] 2006 Worksite Disease Management Programs for Depression: Potential Employer Benefits by Diane E. Steffick & John C. Fortney & Jeffrey L. Smith & Jeffrey M. Pyne [Downloadable!] 2006 Access to Prescription Drugs: The Case of Medicaid by Peter J. Cunningham [Downloadable!] 2006 The Author by Joshua Cohen [Downloadable!] 2006 Comparing Patient Access to Pharmaceuticals in the UK and US by Joel W. Hay [Downloadable!] 2006 Comparison of Individual and Group Valuation of Health State Scenarios across Communities in West Africa by Anayo Fidelis Akunne & John F.P. Bridges & Mamadou Sanon & Rainer Sauerborn [Downloadable!] 2006 Maximising Responses to Discrete Choice Experiments: A Randomised Trial by Joanna Coast & Terry N. Flynn & Chris Salisbury & Jordan Louviere & Tim J. Peters [Downloadable!] 2006 Impact of Cross-Reference Pricing on Pharmaceutical Prices: Manufacturers by Tom Stargardt & Jonas Schreyogg [Downloadable!] 2006 Analysis of Healthcare Financing, Supply and Utilisation Trends in the New EU Countries by Jane E. Ruseski [Downloadable!] 2006 Handling Value Added Tax (VAT) in Economic Evaluations: Should Prices Include VAT? by Mickael Bech & Terkel Christiansen & Dorte Gyrd-Hansen [Downloadable!] 2006 Quality and Cost in Healthcare: A Relationship Worth Examining by Craig Mitton & Francois Dionne & Stuart Peacock & Sam Sheps [Downloadable!] 2006 Acknowledgement by Adis International Limited [Downloadable!] 2006 Patients by Baktygul Akkazieva & Laszlo Gulacsi & Agnes Brandtmuller & Marta Pentek & John F.P. Bridges [Downloadable!] 2006 Comparing Patient Access to Pharmaceuticals in the UK and US by Joshua Cohen & Catherine Cairns & Cherie Paquette & Laura Faden [Downloadable!] 2006 Community-Based Youth Tobacco Control Interventions: Cost Effectiveness of the Full Court Press Project by Hana Ross & Lisa M. Powell & Joseph E. Bauer & David T. Levy & Richard M. Peck & Hye-Ryeon Lee [Downloadable!] 2006 Modelling the Costs and Outcomes of Changing Rates of Screening for Alcohol Misuse by GPs in the Australian Context by Marian Shanahan & Anthony Shakeshaft & Richard P. Mattick [Downloadable!] 2006 To Retain or Remove User Fees?: Reflections on the Current Debate in Low- and Middle-Income Countries by Chris D. James & Kara Hanson & Barbara McPake & Dina Balabanova & Davidson Gwatkin & Ian Hopwood & Christina Kirunga & Rudolph Knippenberg & Bruno Meessen & Saul S. Morris & Alexander Preker & Yves Souteyrand & Abdelmajid Tibouti & Pascal Villeneuve & Ke Xu [Downloadable!] 2006 Estimating Technical Efficiency in the Hospital Sector with Panel Data: A Comparison of Parametric and Non-Parametric Techniques by Luigi Siciliani [Downloadable!] 2006 Supplier-Induced Demand: Reconsidering the Theories and New Australian Evidence by Jeffrey R.J. Richardson & Stuart J. Peacock [Downloadable!] 2006 How Cost-of-Illness Studies Can be Made More Useful for Illicit Drug Policy Analysis by Timothy J. Moore & Jonathan P. Caulkins [Downloadable!] 2006 Centralising Drug Review to Improve Coverage Decisions: Economic Lessons From (and For) Canada by Steve Morgan & Meghan McMahon & Craig Mitton [Downloadable!] 2006 Factors Associated with Physicians by Terhi Kankaanranta & Jari Vainiomaki & Ville Autio & Hannu Halila & Harri Hyppola & Mauri Isokoski & Santero Kujala & Esko Kumpusalo & Kari Mattila & Irma Virjo & Jukka Vanska & Pekka Rissanen [Downloadable!] 2006 Australian General Practice: Where Have the GP Services Gone? by Ian McRae [Downloadable!] 2006 A Macroeconomic Approach to Evaluating Policies to Contain Antimicrobial Resistance: A Case Study of Methicillin-Resistant Staphylococcus aureus (MRSA) by Richard D. Smith & Milton Yago & Michael Millar & Joanna Coast [Downloadable!] 2006 Recycling Blood: Sharing the Benefits of Cell Salvage by Bernard Crotty [Downloadable!] 2006 Using Economic Analyses for Local Priority Setting: The Population Cost-Impact Approach by Richard F. Heller & Islay Gemmell & Edward C.F. Wilson & Richard Fordham & Richard D. Smith [Downloadable!] 2006 The Relationship between Ex Ante Mortality Risk and End-of-Life Medical Costs by David H. Howard & Steven D. Culler & Benjamin G. Druss & Kenneth E. Thorpe [Downloadable!] 2006 Genetic Health Technology and Economic Evaluation: A Critical Review by James Jarrett & Miranda Mugford [Downloadable!] 2006 Methodological Aspects in the Assessment of Treatment Effects in Observational Health Outcomes Studies by Josep Maria Haro & Stathis Kontodimas & Miguel Angel Negrin & Mark Ratcliffe & David Suarez & Frank Windmeijer [Downloadable!] 2006 Health Reform, Equity and Primary Healthcare: Taking Off the Make-Up by Stephen Thomas & Okore Okorafor & Sandi Mbatsha [Downloadable!] 2005 A Rational Irrational Man by Alexander Harin [Downloadable!] 2005 Not the First Digit! Using Benford’s Law to Detect Fraudulent Scientific Data by Andreas Diekmann [Downloadable!] 2005 Scientific Revolution. A Farewell to EconWPA by Alexander Harin [Downloadable!] 2005 Gains and losses. The same or different choices? by Alexander Harin [Downloadable!] 2005 Economic Reform , Labour Training And The Informal Sector- A Theoretical Analysis. by Titas Kumar Bandopadhyay [Downloadable!] 2005 Development Policy And Differential Production Structure In A Harris-Todaro Economy by Titas Kumar Bandopadhyay [Downloadable!] 2005 Chaotic expansion of powers and martingale representation (v1.5) by Farshid Jamshidian [Downloadable!] 2005 A new approach to solve old problems by Alexander Harin [Downloadable!] 2005 The Inflation In European Union by Giovanis Elephtherios [Downloadable!] 2005 The hunting in the Province of Elassona by Giovanis Elephtherios [Downloadable!] 2005 Econometric Analysis of O.U.T.A. – Organisation of Urban Transportations of Athens by Giovanis Elephtherios [Downloadable!] 2005 Econometric Analysis for the rural sector in Greek economy by Giovanis Elephtherios [Downloadable!] 2005 Correlating Growth with Well-Being during Economic Reforms Evidence from India and China by Sudip Ranjan Basu [Downloadable!] 2005 An Integrated Treatment of Monte Carlo Numerical Integration Techniques by J.F. Richard & R. Liesenfeld 2005 Wavelet Optimized Finite-Difference Approach to Solve Jump-Diffusion type Partial Differential Equation for Option Pricing by Mohammad R. Rahman & Ruppa K. Thulasiram & Parimala Thulasiraman [Downloadable!] 2005 Are Voluntary Salary Cap Agreements Self-Enforcing? by Helmut Dietl & Egon Franck & Stephan Nüesch 2005 The Component Fairness Solution for Cycle-free Graph Games by P. Jean-Jacques Herings & Gerard van der Laan & Dolf Talman [Downloadable!] 2005 Markovian Equilibrium in Infinite Horizon Economies with Incomplete Markets and Public Policy by Manjira Datta & Leonard J. Mirman & Olivier F. Morand & Kevin L. Reffett [Downloadable!] 2005 Isotone Recursive Methods: the Case of Homogeneous Agents by Manjira Datta & Kevin L. Reffett [Downloadable!] 2005 Book Review by Adis International Limited [Downloadable!] 2005 Linezolid: A Pharmacoeconomic Review of its Use in Serious Gram-Positive Infections by Greg L. Plosker & David P. Figgitt [Downloadable!] 2005 Cost Effectiveness of Dalteparin for Preventing Venous Thromboembolism in Abdominal Surgery by Adrienne Heerey & Sanjeev Suri [Downloadable!] 2005 Cost-Benefit Analysis of Vaccination against Tick-Borne Encephalitis among French Troops by Guillaume Desjeux & Laurent Galoisy-Guibal & Cyrille Colin [Downloadable!] 2005 A Systematic Review of Patient-Reported Outcome Instruments Measuring Sleep Dysfunction in Adults by Emily Beth Devine & Zafar Hakim & Jesse Green [Downloadable!] 2005 Economic Implications of Biological Therapies for Crohn by Keith Bodger [Downloadable!] 2005 The Role of Economic Evaluation in Vaccine Decision Making: Focus on Meningococcal Group C Conjugate Vaccine by Robert Welte & Caroline L. Trotter & W. John Edmunds & Maarten J. Postma & Philippe Beutels [Downloadable!] 2005 The Authors' Reply by Anthony O'Hagan & Christopher McCabe & Ron Akehurst & Alan Brennan & Andrew Briggs & Karl Claxton & Elisabeth Fenwick & Dennis Fryback & Mark Sculpher & David Spiegelhalter & Andrew Willan [Downloadable!] 2005 Incorporation of Uncertainty in Health Economic Modelling Studies by Mark Nuijten [Downloadable!] 2005 An Economic Evaluation of Rizatriptan in the Treatment of Migraine by Melissa Thompson & Marek Gawel & Brigitte Desjardins & Nicole Ferko & Daniel Grima [Downloadable!] 2005 Cost of Illness and its Predictors for Parkinson's Disease in Germany by Annika E. Spottke & Martin Reuter & Olaf Machat & Bernhard Bornschein & Sonja von Campenhausen & Karin Berger & Rudolf Koehne-Volland & Jurgen Rieke & Alexander Simonow & Dirk Brandstaedter & Uwe Siebert & Wolfgang H. Oertel & Gudrun Ulm & Richard Dodel [Downloadable!] 2005 Economic Evaluation of Temozolomide in the Treatment of Recurrent Glioblastoma Multiforme by Janne A. Martikainen & Akseli Kivioja & Taru Hallinen & Pia Vihinen [Downloadable!] 2005 Societal Discounting of Health Effects in Cost-Effectiveness Analyses: The Influence of Life Expectancy by Suzanne Polinder & Willem Jan Meerding & Job van Exel & Werner Brouwer [Downloadable!] 2005 Parent-Proxy EQ-5D Ratings of Children with Attention-Deficit Hyperactivity Disorder in the US and the UK by Louis S. Matza & Kristina Secnik & Sally Mannix & F. Randy Sallee [Downloadable!] 2005 Granulocyte Colony-Stimulating Factor for Chemotherapy-Induced Neutropenia in Patients with Small Cell Lung Cancer: The 40% Rule Revisited by Elizabeth A. Calhoun & Glen T. Schumock & June M. McKoy & Simon Pickard & Karen A. Fitzner & Elizabeth A. Heckinger & Eowyn F. Powell & Kathyrn R. McCaffrey & Charles L. Bennett [Downloadable!] 2005 Pharmaceutical Policy regarding Generic Drugs in Belgium by Steven Simoens & Kristien De Bruyn & Marc Bogaert & Gert Laekeman [Downloadable!] 2005 Real-World Trials to Answer Real-World Questions by Nick Freemantle & Lawrence Blonde & Bjorn Bolinder & Robert A. Gerber & F.D. Richard Hobbs & Luc Martinez & Stuart Ross [Downloadable!] 2005 The Authors' Reply by Andrew Moore & Ceri Phillips & Elke Hunsche & James Pellissier & Simone Crespi [Downloadable!] 2005 Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK by Eduardo Carracedo-Martinez [Downloadable!] 2005 Costs and Medical Care Consequences Associated with the Diagnosis of Peripheral Arterial Disease by Kristen Migliaccio-Walle & J. Jaime Caro & Khajak J. Ishak & Judith A. OBrien [Downloadable!] 2005 Economic Assessment of Adjustable Maintenance Treatment with Budesonide/Formoterol in a Single Inhaler versus Fixed Treatment in Asthma by Bernd Bruggenjurgen & Dagmar Selim & Peter Kardos & Kai Richter & Claus Vogelmeier & Stephanie Roll & Wolfgang Meyer-Sabellek & Roland Buhl & Stefan N Willich [Downloadable!] 2005 Introducing Economic Evaluation as a Policy Tool in Korea: Will Decision Makers get Quality Information?: A Critical Review of Published Korean Economic Evaluations by Kun-Sei Lee & Werner B.F. Brouwer & Sang-Il Lee & Hye-Won Koo [Downloadable!] 2005 The State of Patient-Reported Outcomes in Atrial Fibrillation: A Review of Current Measures by Karin Coyne & Mary Kay Margolis & Susan Grandy & Peter Zimetbaum [Downloadable!] 2005 Evaluating Health-Related Quality-of-Life Studies in Paediatric Populations: Some Conceptual, Methodological and Developmental Considerations and Recent Applications by Mirella De Civita & Dean Regier & Abul H. Alamgir & Aslam H. Anis & Mark J. FitzGerald & Carlo A. Marra [Downloadable!] 2005 Price Differentiation and Transparency in the Global Pharmaceutical Marketplace by David B. Ridley [Downloadable!] 2005 Discounting Health Effects in Pharmacoeconomic Evaluations: Current Controversies by J.M. Bos & Maarten J. Postma & Lieven Annemans [Downloadable!] 2005 Development of an Economic Model to Assess the Cost Effectiveness of Treatment Interventions for Chronic Obstructive Pulmonary Disease by Michael Spencer & Andrew H. Briggs & Ronald F. Grossman & Laureen Rance [Downloadable!] 2005 The Cost Effectiveness of Infliximab for Severe Treatment-Resistant Rheumatoid Arthritis in the UK by Marco Barbieri & John B. Wong & Michael Drummond [Downloadable!] 2005 Pharmacoeconomic Evaluation of Antidepressants: A Critical Appraisal of Methods by Sheikh Usman Iqbal & Mark Prashker [Downloadable!] 2005 Bipolar Disorder and Health-Related Quality of Life: Review of Burden of Disease and Clinical Trials by Dennis A. Revicki & Louis S. Matza & Emuella Flood & Andrew Lloyd [Downloadable!] 2005 Remission from Depression: A Review of Venlafaxine Clinical and Economic Evidence by Donald Han & Edward C.Y. Wang [Downloadable!] 2005 The Economics of Topical Immunomodulators for the Treatment of Atopic Dermatitis by William Abramovits & Mark Boguniewicz & Amy S. Paller & Diane L. Whitaker-Worth & Mary M. Prendergast & Michael Tokar & Kuo B. Tong [Downloadable!] 2005 Health Utilities in Alzheimer by Peter J. Neumann [Downloadable!] 2005 Incorporation of Uncertainty in Health Economic Modelling Studies by Anthony OHagan & Christopher McCabe & Ron Akehurst & Alan Brennan & Andrew Briggs & Karl Claxton & Elisabeth Fenwick & Dennis Fryback & Mark Sculpher & David Spiegelhalter & Andrew Willan [Downloadable!] 2005 On Pharmacogenomics and Cost-Effectiveness Analysis at the Individual Level by Mohan V. Bala & Gary A. Zarkin [Downloadable!] 2005 Cost Effectiveness of Imatinib Compared with Interferon-alpha or Hydroxycarbamide for First-Line Treatment of Chronic Myeloid Leukaemia by Kim Dalziel & Ali Round & Ruth Garside & Ken Stein [Downloadable!] 2005 Reductions in Anaemia and Fatigue are Associated with Improvements in Productivity in Cancer Patients Receiving Chemotherapy by Ernst Berndt & Joel Kallich & Anne McDermott & Xiao Xu & Howard Lee & John Glaspy [Downloadable!] 2005 Economic Evaluation of Levetiracetam as an Add-On Therapy in Patients with Refractory Epilepsy by Lucie Blais & Odile Sheehy & Jean-Marc Saint-Hilaire & Gilles-Pierre Bernier & Philippe Godfroid & Jacques LeLorier [Downloadable!] 2005 Economic Considerations in the Prescribing of Third-Generation Antidepressants by Stuart Montgomery & John J. Doyle & Lee Stern & Christopher R. McBurney [Downloadable!] 2005 The Health-Related Quality of Life and Economic Burden of Constipation by Cheryl Dennison & Manishi Prasad & Andrew Lloyd & Samir K. Bhattacharyya & Ravinder Dhawan & Karin Coyne [Downloadable!] 2005 Valuing Patient and Caregiver Time: A Review of the Literature by Jennifer E. Tranmer & Denise N. Guerriere & Wendy J. Ungar & Peter C. Coyte [Downloadable!] 2005 Does Pharmacogenomics Provide an Ethical Challenge to the Utilisation of Cost-Effectiveness Analysis by Public Health Systems? by Adam La Caze [Downloadable!] 2005 Effects of Antidepressants on Quality of Life in Women with Premenstrual Dysphoric Disorder by Ellen W. Freeman [Downloadable!] 2005 Willingness to Pay for a QALY: Theoretical and Methodological Issues by Dorte Gyrd-Hansen [Downloadable!] 2005 Quality Control in the Regulation of Pharmaceuticals by Alan Maynard [Downloadable!] 2005 Modelling Cost Effectiveness and Cost Utility of Sequential DMARD Therapy Including Leflunomide for Rheumatoid Arthritis in Germany: II. The Contribution of Leflunomide to Efficiency by Peter K. Schadlich & Henning Zeidler & Angela Zink & Erika Gromnica-Ihle & Matthias Schneider & Christoph Straub & Josef G. Brecht & Eduard Huppertz [Downloadable!] 2005 Modelling Cost Effectiveness and Cost Utility of Sequential DMARD Therapy Including Leflunomide in Rheumatoid Arthritis in Germany: I. Selected DMARDs and Patient-Related Costs by Peter K. Schadlich & Henning Zeidler & Angela Zink & Erika Gromnica-Ihle & Matthias Schneider & Christoph Straub & Josef G. Brecht & Eduard Huppertz [Downloadable!] 2005 Cost Effectiveness of Budesonide/Formoterol in a Single Inhaler for COPD Compared with Each Monocomponent Used Alone by Claes-Goran Lofdahl & Asa Ericsson & Klas Svensson & Emma Andreasson [Downloadable!] 2005 Health-Related QOL in Acute Exacerbations of Chronic Bronchitis and Chronic Obstructive Pulmonary Disease: A Review of the Literature 
